Literature DB >> 7426350

Improving the therapeutic index of two alkylating agents.

J L Millar, R D Clutterbuck, I E Smith.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7426350      PMCID: PMC2010424          DOI: 10.1038/bjc.1980.263

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan.

Authors:  D W Hedley; T J McElwain; J L Millar; M Y Gordon
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

2.  Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents.

Authors:  J L Millar; N M Blackett; B N Hudspith
Journal:  Cell Tissue Kinet       Date:  1978-09

3.  Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide.

Authors:  J L Millar; B N Hudspith; T J McElwain; T A Phelps
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  3 in total
  4 in total

1.  Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells.

Authors:  C Bryce Johnson; Bennett R May; Brian P Riesenberg; Samantha Suriano; Shikhar Mehrotra; Elizabeth Garrett-Mayer; Mohamed L Salem; Emily K Jeng; Hing C Wong; Chrystal M Paulos; John M Wrangle; David J Cole; Mark P Rubinstein
Journal:  Cancer Res       Date:  2018-04-10       Impact factor: 12.701

2.  Priming with low doses of methyl-CCNU reduce the toxicity of high doses of methyl-CCNU and melphalan, and increase the lifespan of mice implanted with Lewis lung carcinoma.

Authors:  A Zimber; K Perk; I Livnat
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

3.  Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.

Authors: 
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

4.  High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice.

Authors:  B D Evans; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.